Top rated products
-
308.00 - 63.00
- 756.00
- 77.00
- 248.00
Puga Khand (Suparipak) 250grm.
143.00
PUGA KHAND (SUPARIPAK) is an ayurvedic and herbal medicine. PUGA KHAND (SUPARIPAK) is an Ayurvedic medicine manufactured by Multani Pharmaceuticals Ltd. It is to be taken orally. PUGA KHAND (SUPARIPAK) is used in the treatment of, weakness, and backache & for general debility.
Out of stock
PUGA KHAND (SUPARIPAK) is an ayurvedic and herbal medicine. PUGA KHAND (SUPARIPAK) is an Ayurvedic medicine manufactured by Multani Pharmaceuticals Ltd. It is to be taken orally. PUGA KHAND (SUPARIPAK) is used in the treatment of, weakness, and backache & for general debility.
- It is 100% Ayurvedic and safe.
ACTIVE Ingredients:-
Indications:-Health Supplement.
Dosages :-3-6 g with warm milk or as directed by the physician.
Manufactured By:-
Multani Pharmaceuticals Ltd.
Tags: Female Health Supplement
Related products
Sundari Jeevak 450ml.
308.00Read moreSUNDARI JEEVAK is a proprietary Ayurvedic medicine manufactured by Multani Pharmaceuticals. It is mainly used for woman’s problems. Herbal uterine tonic. Useful in various feminine problems.
Sarvin Syrup 100ml.
48.00Read moreSARVIN SYRUP is a proprietary Ayurvedic medicine manufactured by Multani Pharmaceuticals Ltd. It is mainly used to Skin Disorder & Helps in Controlling Acne & Pimples, Controlling Natural BLOOD PURIFIER, & Controlling Skin Allergies.
Shaktiton Bal Tonic 450ml.
154.00Read moreINGREDIENTS:-
- Ashwagandha
- Safed Musli
- Triphala
- Chitrakmula
- Mahua
- Draksha
- Manjishtha
- Arjun Chhal
- Pippli
- Gokhru
- Nagarmotha
- Sonth
- Madhya
Indications:-General Debility & Health Tonic.
Kuka Cough Lozenges (Tulsi Lemon) 150 Loz.
135.00Read moreKuka Cough TULSI LEMON by Multani, Helpful ayurvedic medicine for Sore Throat, Pharyngitis, Laryngitis. Kuka Cough Lonzeges helps in cough problems.
- It is 100% Ayurvedic and safe.
Indications:-Use for Sore throat.
Products
- 810.00
- 473.00
- 473.00
- 473.00
- 158.00
- 308.00
- 32.00
Product Showcase
Reviews
There are no reviews yet.